KR840001970A - 아미노 사이클로펜탄산 및 에스테르의 제조방법 - Google Patents

아미노 사이클로펜탄산 및 에스테르의 제조방법 Download PDF

Info

Publication number
KR840001970A
KR840001970A KR1019820004870A KR820004870A KR840001970A KR 840001970 A KR840001970 A KR 840001970A KR 1019820004870 A KR1019820004870 A KR 1019820004870A KR 820004870 A KR820004870 A KR 820004870A KR 840001970 A KR840001970 A KR 840001970A
Authority
KR
South Korea
Prior art keywords
carbon atoms
alkyl
phenyl
och
product
Prior art date
Application number
KR1019820004870A
Other languages
English (en)
Other versions
KR870001026B1 (ko
Inventor
윌리암 콜링톤 에릭 (외 6)
Original Assignee
베리 에이 뉴삼
글락소 그룹 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베리 에이 뉴삼, 글락소 그룹 리미티드 filed Critical 베리 에이 뉴삼
Publication of KR840001970A publication Critical patent/KR840001970A/ko
Application granted granted Critical
Publication of KR870001026B1 publication Critical patent/KR870001026B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

아미노 사이클로펜탄산 및 에스테르의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (13)

  1. (a) R1이 -OH또는 후술한 (1)형태의 그룹인 화합물을 제조하기 위해서 상응하는 다음 일반식 (2)화합물을 환원시키고; (b) R1이 -OH인 화합물을 제조하기 위해서는, 상응하는 에스테르를 가수분해하고, (c) R1이 -OH가 아닌 화합물을 제조하기 위해선, 상응하는 카복실산을 에스테르화하고; (d) X가 아세틸렌그룹이 상응하는 화합물을 환원시키거나;(e) R1이 후술한 (a)형태(여기서 R3는 아미노로 치환된 페닐이다)의 그룹인 화합물을 제조하기 위해서는, R3가 아지도로 치환된 페닐이 상응하는 화합물을 환원시키며; (f) X가 -CH2CH2-인 화합물을 제조하기 위해서는, X가 --CH=CH-인 상응하는 화합물을 촉매적으로 수소화시키고; (g) R1이 -OH 또는 후술한 (1)형태의 그룹인 화합물을 제조하기 위해서는, 환하이드록시그룹이 α-배위인 상응하는 화합물을 에피머화하며; (h) R1이 -OH인 화합물을 제조하기 위해서는 다음 일반식(4)의 상응화합물을 일반식 (R15)3P=CHWCOOH (여기서 R15는 탄소수 1내지 6의 알킬 또는 아릴이다)이 포스포란 또는 그 염과 반응시키며; (i) R1이 -OH인 화합물을 제조하기 위해서는 다음 일반식(6)의 상응알콜을 선택적으로 산화시키며; (j) X가 트랜스-CH=CH-이며 R1이 -OH 또는 후술한 (1)형태의 그롤인 화합물을 제조하기위해서는, 상응하느 시스화합물을 이성체화하고; (k)환하이드록시그룹이 보호된 상응하는 화합물로부터 보호그룹을 제거하거나; (1) 염을 제조하기 위해, 일반식(1)의 화합물을 산 또는 염기로 처리하거나, 한가지 염을 양이온교환에 의해 다른 염으로 전환시키는 것을 포함하여, 다음 일반식(1)의 화합물 및 그의 생리학적으로 허용되는 염 및 용매화물을 제조하는 방법.
    상기식에서 R1은 -OH; (a) -AR3, 여기서 A는 -0- 또는 -S-이며 R3는 페닐 [탄소수 1내지 4의 알킬, 탄소수 1내지 4의 알콕시, 탄소수 1 내지 4의 알카노일, 메틸티오, 메틸설피닐, 메틸서포닐, 할로겐, -CO2R4(R4는 수소원자 또는 탄소수 1내지 4의 알킬 또는 페닐이다), -NHCOR4, -CONP5R9(R5및 R6는 같거나 다를 수 있으며 각각 수소원자 또는 탄소수 1 내지 4의 알킬이다), 탄소수 1내지 4의 알킬설포닐-아미노, 포르밀, 니트로, 시아노, 페닐 또는 -NR5R6로 임의 치환됨]이며;(b) -OCH2COR7,여기서 R7은 페닐(할로겐원자, 탄소수 1 내지 4의 알킬 또는 탄소수 1 내지 4의 알콕시로 임의 치환됨) 또는 -NH2이며; (c) -A(CH2)mBR5, 여기서 m은 1 내지 3이며 B는 -0- 또는 -S-인데, 단, m이 1일 때 R5는 수소원자가 아니며; (d) -A(CH2)pR8, 여기서 q는 2 또는 3이며 R8은 N-부착_탄소수 1 내지 4의 디알킬아미노, 모르폴리노, 피페리디노, 피롤리디노, 아세틸아미노 또는 벤조일아미노그룹이며; (e) -OCH(CH2N(CH3)2)2; (f)여기서 R9는 수소원자, 메틸 또는 페닐이며; (g) -OCH2OCOR10, 여기서 R10은 탄소수 1내지 4의 알킬, 메톡시 또는페닐이며; (h) -OCH2SCOR11, 여기서 R11은 탄소수 1내지 4의 알킬이며;(i)피리디닐옥시 또는피리디닐티오; (j) 1-(아세틸옥시)에톡시, (아세틸옥시)페닐메톡시, 테트라하이드로-5-옥소-2-푸라닐옥시, 테트라하이드로소-2-옥소-3-푸라닐옥시, 트리페닐메톡시 또는 디페닐-메톡시;(k) -OR12, 여기서 R12는 탄소수 3내지 6의 알케닐, 하나이상의 탄소수 1내지 4인 알킬그룹, -CH2CCl3또는 푸라닐메틸로 임의치환된 탄소수 5내지 7의 사이클로알킬이며; 또는 (1)탄소수 1 내지 6의 알콕시 또는 탄소수 7내지 10의 아르알콕시이며; n은 1 또는 2이며; W는 직쇄 또는 측쇄의 탄소수 1 내지 7 의 알킬렌이며; X는 시스 또는 트랜스형의 -CH=CH- 또는 -CH2CH2-이며; Y는 (i) 5 내지 8원이며 하나이상의 탄소수 1 내지 4의 알킬그룹으로 임의치환된 포화헤테로- 사이클릭아미노그룹(질소원자에 의해 사이클로펜탄환에 부착된다); 또는(ii)모르폴리노(단, Y가 모르폴리노이면, R1은 -OH 또는 그룹(1)이며, -(CH2)nXWCOR1그룹과 연결된 탄소원자는 R배위이다)이며; R2는 (i)(a) 페닐[탄소수 1내지 6의 알킬, 탄소수 5내지 7의 사이클로알킬, 페닐알킬(알킬부위의 탄소수는 1내지 5이다), 티에닐, 페닐(탄소수 1 내지 4의 알킬, 탄소수 1 내지 4의 알콕시 또는 페닐로 임의 치환됨), 벤조일(탄소수 1 내지 4의 알킬, 탄소수 1 내지 4의 알콕시, 할로겐 , 트리-플루오르메틸 똔느 페닐로 임의 치환됨) 또는 탄소수 5 내지 7의 사이클로알카노일로 임의 치환된], (b) 티에닐[탄소수 1 내지 6의 알킬, 탄소수 1내지 6의 알콕시, 탄소수 5내지 7의 사이클로알킬 또는 페닐(탄소수 1 내지 3의 알킬, 탄소수 1 내지 3의 알콕시 또는 할로겐으로 임의 치환됨)로 임의 치환됨], 또는 (c) 탄소수 1 내지 5의 알킬, 또는 (ii) 벤조일로 임의 치환된 신나밀이다.
  2. 제1항에 있어서, 생성물의 X가 시스 -CH=CH-인 제조방법
  3. 제1 또는 2항에 있어서, 생성물의 n이 2이며 w는 -CH2CH2- 또는 -CH2CH2CH2CH2인 제조방법.
  4. 전술한 항중의 어느하나에 있어, 생성물의 R1은 -OH, -OCH3, -OCH2OCOCH2, -OCH2SCH2, -OCH2CH2CH2NHCOCH2,-OCH2CONH2, 4-아세트아미도펜옥시 또는 알릴옥시인 제조방법.
  5. 전술한 항중의 어느 하나에 있어서, 생성물의 R2가 벤질그룹이며, 이의 페닐부위는 티에닐 또는 페닐(이는 탄소수 1내지 4의 알킬 또는 탄소수 1내지 4의 알콕시로 임의 치환됨)로 치환된 제조방법
  6. 제1항에 있어서, 생성물이 일반식(1)[R1이 -OH, -OCH3, -OCH2OCOCH2, -OCH2SCH2, -OCH2CH2CH2NHCOCH2, -OCH2CONH2, 4-아세트아미도펜옥시 또는 아릴옥시이며; w는 -CH2CH2-이며; n은 2이고; X는 시스-CH=CH이며; Y는 피페리디노 또는 모르폴리노(단Y가 모르폴리노이고 R1이 -OH 또는 -OCH3이면 -(CH2)nXWCOR1그룹과 연결된 탄소원자는 R-배위이다)이며; R2는 페닐그룹이 페닐, 톨릴 또는 메톡시페닐로 치환된 벤질이다] 또는 그의 생리학적으로 허용되는 염 또는 용매화물인 제조방법.
  7. 전술한 항중의 어느 하나에 있어, 생성물의 Y가 피페리디노인 제조방법.
  8. 전술한 항중의 어느 하나에 있어, 생성물의 R1이 -OH인 제조방법.
  9. 전술한 항중의 어느 하나에 있어, 생성물의 -(CH2)nXWCOR1그룹과 연결된 탄소원자가 R-배위인 제조방법.
  10. 제1항에 있어, 생성물이 [1α(Z),2β,3β,5α]-(±)-7-[5-[[(1,1'-비페닐)-4-일]메톡시]-3-하이드록시-2-(1-피페리디닐)사이클로펜틸]-4-헵테노산 또는 그의 생리학적으로 허용되는 염 또는 용매화물인 제조방법.
  11. 제1항에 있어, 생성물이 [1R-[1α(Z),2β,3β,5α]-(+)-7-[5-[[(1,1'-비페닐)-4-일]메톡시]-3-하이드록시-2-(1-피페리디닐)사이클로펜틸]-4-헵테노산 또는 그의 생리학적으로 허용되는 염 또는 용매화물인 제조방법.
  12. 제11항에 있어, 생성물이 상기 화합물이 염산염인 제조방법.
  13. 제1항에 있어서, 생성물이 [1R-[1α(Z),2β,3β,5α]-(+)-7-[5-[[(1,1'-비페닐)-4-일]메톡시]-3-하이드록시-2-(4-모르폴리닐)-사이클로펜틸]-4-헵테노산 또는 그의 생리학적으로 허용되는 염 또는 용매화물인 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR8204870A 1981-10-29 1982-10-28 아미노 사이클로펜탄산 및 에스테르의 제조방법 KR870001026B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8132675 1981-10-29
GB8132675 1981-10-29
GB8212489 1982-04-29
GB8212489 1982-04-29

Publications (2)

Publication Number Publication Date
KR840001970A true KR840001970A (ko) 1984-06-07
KR870001026B1 KR870001026B1 (ko) 1987-05-25

Family

ID=26281113

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8204870A KR870001026B1 (ko) 1981-10-29 1982-10-28 아미노 사이클로펜탄산 및 에스테르의 제조방법

Country Status (7)

Country Link
US (1) US4482549A (ko)
KR (1) KR870001026B1 (ko)
FI (1) FI77242C (ko)
GR (1) GR77728B (ko)
IL (1) IL67041A (ko)
PH (1) PH18473A (ko)
PT (1) PT75762A (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100373439B1 (ko) * 1998-08-27 2003-05-17 서완용 원거리전화단선체크장치

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307099D0 (en) * 1983-03-15 1983-04-20 Glaxo Group Ltd Carbocyclic compounds
LU85528A1 (fr) * 1983-09-06 1985-04-29 Glaxo Group Ltd Aminocyclopentanes et leur procede de preparation
GB8601985D0 (en) * 1986-01-28 1986-03-05 Glaxo Group Ltd Chemical process
GB8625326D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Medicaments
US5371096A (en) * 1993-08-27 1994-12-06 Ciba-Geigy Corporation (3-pyridyl)tetrafuran-2-yl substituted carboxylic acids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189606A (en) * 1976-02-23 1980-02-19 Gruppo Lepetit S.P.A. 13-Azaprostaglandins
GB1553293A (en) * 1976-02-23 1979-09-26 Lepetit Spa Azaprostaglandins
DE2927855A1 (de) * 1978-07-11 1980-03-20 Glaxo Group Ltd Prostanoid-verbindungen
US4239778A (en) * 1978-09-12 1980-12-16 The University Of Illinois Foundation Azaprostanoic acid analogs and their use as inhibitors of platelet aggregation
JPS5718671A (en) * 1980-04-30 1982-01-30 Glaxo Group Ltd Aminocyclopentane alkenoic acid and esters thereof,manufacture and drug composition
US4371530A (en) * 1980-07-04 1983-02-01 Glaxo Group Limited Aminocyclopentanone amides and pharmaceutical formulation
DE3162659D1 (en) * 1980-07-22 1984-04-19 Ono Pharmaceutical Co 9,11-methano-13-aza-11a-carbathrombanoic acid analogues and pharmaceutical use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100373439B1 (ko) * 1998-08-27 2003-05-17 서완용 원거리전화단선체크장치

Also Published As

Publication number Publication date
PT75762A (en) 1982-11-01
GR77728B (ko) 1984-09-25
FI77242C (fi) 1989-02-10
FI77242B (fi) 1988-10-31
FI823690A0 (fi) 1982-10-28
PH18473A (en) 1985-07-18
IL67041A (en) 1988-03-31
KR870001026B1 (ko) 1987-05-25
US4482549A (en) 1984-11-13
IL67041A0 (en) 1983-02-23
FI823690L (fi) 1983-04-30

Similar Documents

Publication Publication Date Title
IE43600L (en) Prost-16-ynoic acid derivatives.
KR840001970A (ko) 아미노 사이클로펜탄산 및 에스테르의 제조방법
JPS51149247A (en) Prostaglandin analogues, process for their preparation and drug compos itions containing them as effective ingredients
US4582857B1 (en) P-oxybenzoic acid derivatives processes for their production and their use as drugs
KR860000236A (ko) 유기산의 트리테르페닐의 에스테르의 제조방법
IE780718L (en) Pyrroloquinoxalines
ES459903A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinoleina.
HUT40661A (en) Process for producing carbapenem derivatives
GB1502328A (en) Prostaglandin derivatives
IE831624L (en) Bicyclo£3,2,0| heptanone oxime ethers
GB1508168A (en) 11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandins
EP0064286A3 (en) New derivatives of alkanediols having hypolipidaemic activity, methods for their preparation and pharmaceutical compositions containing them
GB1497011A (en) 2-(omega-haloalkenyl-cyclopentane-1-heptanoic acids methods for preparation thereof and their use
SE7601948L (sv) Sett att framstella karboxi-alkan-fosfonsyror och karboxi-alkyl-fosfinsyror
IE790299L (en) Testosterone esters
JPS5419946A (en) Prostaglandin analog compound and their preparation
JPS51122040A (en) A process for preparing prostaglandin analogues
JPS545953A (en) Prostaglandin analogous compounds, process for their preparation and pharmaceutical composition containing the same as active constituents
JPS5589245A (en) 9,10-dihydroanthracene-2-alkanoic acid derivative
DE3578068D1 (de) 3,5-dialkyl-4,6-diaryl-tetrahydro-2h-1,3,5-thiadiazin-2-thion-derivate, verfahren zu ihrer herstellung und sie enthaltende antihyperlipidemische mittel.
JPS5297943A (en) Prostaglandin derivatives
JPS52133960A (en) 2-cyano-3-methyl-3-(6-methoxy-2-naphthyl)-glycidic acid and method of preparing the same
JPS5265251A (en) Synthesis of prostaglandin derivatives
ATE58468T1 (de) Sebosuppressive kosmetische mittel, enthaltend benzoesaeureesterderivate, sowie neue benzoesaeureesterderivate.
ES478073A1 (es) Un procedimiento de preparacion de benzamidas.